LGALS3BP and choriocarcinoma: The concentration of LGALS3BP was significantly elevated in serum samples from patients with MTX-resistant choriocarcinoma compare to MTX-sensitive choriocarcinoma (P < 0.01) (Figure 2(d); Table 3).